Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aptiv PLC (APTV) vs Novavax Inc (NVAX) Price & Performance

Novavax IncTrade

Price performance (Past 24H)

Key statistics

Aptiv PLC vs Novavax Inc — how do they compare? Aptiv PLC trades at $50.28 (market cap $10.30B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Aptiv PLC is far larger — about 7.9× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Aptiv PLC nearer its low. Which is the better fit depends on your goals.

APTVNVAX
Market Cap
$10.30B$1.31B
Sector
Consumer CyclicalHealth
52-Week High
$76.82$11.19
52-Week Low
$46.30$6.22
Enterprise Value
$15.23B$889.30M

Returns comparison

Trailing returns across standard periods

About Aptiv PLC

Aptiv's signal and power solutions segment supplies components and systems that make up a vehicle's electrical system backbone, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The advanced safety and user experience segment provides body controls, infotainment and connectivity systems, passive and active safety electronics, advanced driver-assist technologies, and displays, as well as the development of software for these systems. Aptiv's largest customer is General Motors at roughly 12% of 2021 revenue, including sales to GM's Shanghai joint venture, followed by Stellantis at 11%, and Volkswagen at 9%. North America and Europe represented approximately 38% and 33% of total 2019 revenue, respectively.

Read more on APTV

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX